| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.009 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |